Quest Diagnostics Foundation
Quest Diagnostics Foundation is the 501(c)(3) charitable arm of Quest Diagnostics Incorporated (NYSE: DGX). The parent operates a national clinical laboratory network running 200+ million tests per year for half of U.S. physicians and hospitals, and the Foundation funds community health and wellness programs in partnership with public health and anti-hunger organizations.
- Company typePublic
- Founded1991
- HeadquartersSecaucus, United States
- Headcount5,001–10,000
- GTM typeB2B
- OfferingServices
What Quest Diagnostics Foundation does
Quest Diagnostics Foundation is the 501(c)(3) charitable arm of Quest Diagnostics Incorporated (NYSE: DGX), a leading U.S. diagnostic information services company. Founded in 1991, the Foundation promotes healthcare and wellness through community health initiatives and has committed approximately $53 million to such programs since 2021, including a $5 million multi-year partnership with Miami-Dade County. The Foundation operates without a separate parent entity, and its funded work — including deployments such as the U.S. Hunger AI-powered Full Cart Connect food-as-medicine platform — is resourced by the operating parent company.
The underlying operating company, Quest Diagnostics, provides clinical laboratory testing and diagnostic information services including molecular/PCR testing, serology, genetic testing, anatomic pathology, advanced genomics, and reproductive and women's health testing. It operates 2,000+ patient service centers and 7,700 patient access points, performs more than 200 million tests annually, and serves roughly half of U.S. physicians and hospitals. Specialty subsidiaries include AmeriPath (anatomic pathology), Cleveland HeartLab (cardiometabolic), Athena Diagnostics (neurology), Blueprint Genetics (rare-disease genetics, 70+ countries), PhenoPath and Dermpath Diagnostics (dermatopathology), Haystack Oncology (ctDNA MRD liquid biopsy, acquired 2023), and Pack Health (digital patient engagement, acquired 2022). The technology stack spans proprietary assay development, integrations with 850+ EHR systems, the Quest AI Companion for patient result interpretation, and AI-empowered analytics within Blueprint Genetics.
The business model is transaction-based, with per-test pricing billed primarily through payer reimbursement (the company reports in-network coverage of 90% of insured lives) and a growing direct-to-consumer channel via questhealth.com. Customer segments span physicians, hospitals and health systems, employers, health plans, life sciences companies, and individual consumers. Reported revenue was $9.88 billion in 2022 (elevated by COVID-19 testing) and was guided to $8.93B–$9.08B for 2023, with disclosed commentary indicating that base-business revenues were growing as pandemic-related testing volumes normalized.
Quest Diagnostics Foundation firmographics
Firmographics- Name
- Quest Diagnostics Foundation
- Legal name
- Quest Diagnostics Incorporated
- Website
- https://questdiagnostics.com
- Company type
- Public
- Founded year
- 1991
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- Quest Diagnostics Foundation is the 501(c)(3) charitable arm of Quest Diagnostics Incorporated (NYSE: DGX). The parent operates a national clinical laboratory network running 200+ million tests per year for half of U.S. physicians and hospitals, and the Foundation funds community health and wellness programs in partnership with public health and anti-hunger organizations.
- Ownership category
- akta.pro rank
Quest Diagnostics Foundation industry classification
Industry- Product category
- Healthcare Philanthropy
- NAICS
- Grantmaking Foundations (813211), Voluntary Health Organizations (813212)
- SIC
- Services-Social Services (8300)
- akta.pro primary industry
- Health & Medical Research Grantmaking Foundations (BPAGAKAL)
- akta.pro secondary industry
- Community Health, Prevention & Health Education (BPAGACAC)
Keywords
Where Quest Diagnostics Foundation is headquartered
LocationHeadquarters
- HQ city
- Secaucus
- HQ country
- United States
- HQ region
- North America
Offices8 records
Markets served
Quest Diagnostics Foundation business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Operations, Personnel, Marketing or Sales, Others
Revenue model
- Diagnostic Information Services: Clinical laboratory testing services provided to healthcare providers and patients, including routine and specialty tests across multiple disease categories.
- COVID-19 Testing: Molecular (PCR), rapid antigen, and antibody testing for SARS-CoV-2, with revenues declining post-pandemic from peak levels.
- Consumer-Initiated Testing: Direct-to-consumer lab tests purchased online through questhealth.com without doctor's order, including STI self-collection and various panel tests.
- Enterprise/B2B Services: Laboratory services for hospitals, health systems, employers, health plans, and life sciences companies including drug screening, population health, and clinical trials.
- Base Business Revenues: Core diagnostic testing revenues excluding COVID-19 testing, representing routine and specialty laboratory services.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Transaction based/ take rate | Pay-as-you-go | Standard diagnostic testing services |
| Unit Pricing | Pay-as-you-go | Consumer-initiated testing (questhealth.com) |
| Other | Pay-as-you-go | Financial assistance programs |
Go-to-market motion4 records
Distribution channels6 records
Marketing channels8 records
Quest Diagnostics Foundation product offering
Product offeringCore offering
Quest Diagnostics Foundation is a 501(c)(3) nonprofit corporation that promotes healthcare and wellness benefits and disease prevention through grant-making and community health initiatives. The Foundation has committed approximately $53 million to community initiatives since 2021, awarding grants to nonprofits in cities such as Baltimore, Houston, Chicago, Paterson, and Miami-Dade County, with a focus on maternal health, cardiometabolic outcomes, food security, and health equity in underserved communities.
Product overview
Quest Diagnostics is a diagnostic information services company offering a comprehensive portfolio of laboratory tests and health technology solutions. The core offerings include MyQuest patient portal and Quanum Lab Services Manager for healthcare providers. Key specialty brands include AmeriPath (anatomic pathology), Cleveland HeartLab (cardiometabolic testing), Athena Diagnostics (neurological testing), Blueprint Genetics (genetic testing), and PhenoPath/Dermpath Diagnostics (dermatopathology/cancer diagnostics). The company recently acquired Haystack Oncology for minimal residual disease (MRD) liquid biopsy testing. Additional services include health coaching through Pack Health, thousands of routine and specialty lab tests, and population health solutions. Quest serves half of U.S. physicians and hospitals, with approximately 3,500+ lab tests available across 2,000+ patient service centers.
Differentiator
Problem solved
Functional benefit
Brands
- Quanum Lab Services Manager: Online business tool for physicians, hospital, and office staff to order lab tests and view patient results
- MyQuest
- Quest Mobile
- Quest Health
- Haystack MRD
- Cleveland HeartLab
- AmeriPath
- Athena Diagnostics
- Pack Health
Products and services
- Community Health Grants Program Grant-making program through which the Foundation awards funding to community-based nonprofit organizations working on health equity, maternal health, cardiometabolic disease prevention, and food security in underserved U.S. communities.
- Healthy Communities Champions Award Recognition program honoring up to 15 individuals or organizations committed to improving health in their communities, each receiving a $5,000 grant to support their community health work.
- Miami-Dade County Health Initiative Multi-year initiative committing nearly $5 million in grant funding to four local nonprofit organizations in Miami-Dade County, Florida, to improve chronic and maternal health outcomes and food security, with a goal of reaching up to 15,000 residents over a 2-year period.
- Multi-Year Health Equity Initiative Joint $100+ million initiative launched by Quest Diagnostics and the Foundation to improve health, with initial focus on communities hit hardest by COVID-19 and continuing focus on health equity, chronic disease prevention, and community health workforce.
Quantifiable outcome
- ApoB testing rates doubled between 2021-2023, reaching 1.8% of at-risk patients, though still extremely low relative to standard lipid panel testing
- +2 more outcomes
Companies that use Quest Diagnostics Foundation
Customer profileNamed customers7 records
Segments7 records
Ideal customer profiles1 record
Quest Diagnostics Foundation technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration5 records
AI capability5 records
Feature9 records
Quest Diagnostics Foundation partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core, flagship and minor.
- Florida International University Foundationcore$5 million foundation grant for maternal health services across Miami-Dade County maternal health deserts, expanding Black Mothers Care Plan through mobile units and midwifery services.
- Urban Health PartnershipscoreFoundation grant recipient coordinating Food and Nutrition for All Collaborative (FNFA), strengthening governance and shared data infrastructure, supporting mini-grants for up to 16 community organizations.
- The Health Council of South FloridacoreFoundation grant recipient serving as evaluation partner to measure effectiveness of initiative, conducting equity-focused analysis of food access, maternal health, and chronic disease prevention.
- U.S. HungercoreFoundation grant recipient deploying AI-powered Full Cart Connect Platform to identify and direct support to households in need throughout Miami-Dade County.
- Hackensack Meridian Center for Discovery and Innovation (CDI)flagshipCollaborative research on antibiotic-resistant bacteria. Quest provided deidentified culture isolates from nationwide network for CDI sequencing analysis. Study published in Nature Communications identified multidrug-resistant Klebsiella pneumoniae spread across 42 states.
- Haystack OncologycoreQuest acquired Haystack Oncology for $300 million (plus up to $150M milestones) to add minimal residual disease (MRD) liquid biopsy testing. Haystack developed tumor-informed ctDNA technology based on 20 years of Johns Hopkins research for early detection of residual or recurring cancer.
- NewYork-PresbyteriancoreQuest completed acquisition of select laboratory services assets of NewYork-Presbyterian. Goal is to enable providers and patients to access high quality, affordable testing combining complementary strengths of both organizations with access to Quest's network of nearly 100 patient service centers.
- Tower HealthcoreQuest provides laboratory supply chain expertise and reference testing for regional integrated healthcare system in Pennsylvania.
- Pack HealthcoreQuest acquired Pack Health to add digital patient engagement and health coaching capabilities. Pack Health provides health coaching for chronic disease management programs, including diabetes, and expanded headquarters in Birmingham, Alabama with at least 200 new full-time jobs.
- CDC (ICATT Program)flagshipQuest is the only major laboratory provider in CDC's Increasing Community Access to Testing program supporting testing access for uninsured in underserved communities.
- Mobile Care ChicagominorCommunity partnership delivering healthcare services to vulnerable children in Chicago through mobile van services.
Scale indicators16 records
Recent moves7 records
Expansion highlights6 records
Quest Diagnostics Foundation competitors and assessment
Company assessmentDirect peers
- Pfizer Foundation: Corporate foundation of a major pharmaceutical company funding community health, health workforce, and health-equity initiatives globally. Same corporate-foundation structure, comparable grant size, and overlap in target disease areas (cardiovascular, infectious disease).
- Eli Lilly Foundation: Corporate foundation of a major pharmaceutical company supporting community health and disease-specific initiatives. Direct structural peer as a publicly traded pharma parent with a separately governed corporate foundation.
- Bristol Myers Squibb Foundation: A major pharmaceutical corporate foundation funding health-equity, oncology, and cardiovascular community programs. Closely comparable in structure as a corporate-foundation grantmaker, with similar disease-area and disparities focus and grantee-driven delivery model.
- Kaiser Permanente Community Health: Community health arm of a large integrated US health system, funding community health, maternal/child health, and chronic disease prevention in served and underserved markets. Comparable as a healthcare-organization grantmaker targeting similar disease areas and populations.
- UnitedHealth Foundation: Corporate foundation of a major US health insurer funding community health, maternal/child health, and workforce initiatives. Closely comparable scale, grantmaking structure, and disease-area focus to the Quest Diagnostics Foundation.
- ARUP Laboratories: Nonprofit academic clinical laboratory affiliated with the University of Utah, providing reference and esoteric diagnostic services. Closely comparable in business model (diagnostics) and nonprofit structure, making it the closest structural peer if the comparison expands to the Foundation's parent context.
Broad incumbents
- Robert Wood Johnson Foundation: The largest US philanthropy focused exclusively on health, RWJF funds community health, maternal/child health, and health-equity initiatives across many markets. It is the benchmark independent health-focused grantmaking foundation and the most relevant peer for the Quest Diagnostics Foundation's mission and grantmaking model.
- CDC Foundation: Independent nonprofit that mobilizes philanthropic and private-sector resources to support CDC priorities in public health, health equity, and disease prevention. Comparable as a public-health-focused grantmaking organization, though with broader public-sector and global scope.
- Sonic Healthcare: Global clinical laboratory and diagnostic services company with US operations through affiliated brands. Comparable to Quest Diagnostics at the parent-company level in core diagnostics business, providing indirect context for the Foundation's strategic priorities.
- Labcorp (Laboratory Corporation of America): Direct competitor to Quest Diagnostics Incorporated (the parent of the Foundation) in clinical laboratory services. Most relevant peer for the broader organization, though Labcorp's corporate foundation activities are a subset of its scale.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights6 records
Customer concentration
Quest Diagnostics Foundation social profiles
Digital presenceQuest Diagnostics Foundation compliance and trust
Trust signalCompliance4 records
Quest Diagnostics Foundation financial estimates
Financial estimateRevenue estimate
Valuation estimate
Quest Diagnostics Foundation leadership team
Management profileNumber of profiles
Profiles1 record
Quest Diagnostics Foundation subsidiaries and ownership
Company hierarchySubsidiaries9 records
Quest Diagnostics Foundation funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Quest Diagnostics Foundation M&A and investment
M&A and investmentM&A
Investments3 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Quest Diagnostics Foundation
What does Quest Diagnostics Foundation do?
Quest Diagnostics Foundation is a 501(c)(3) nonprofit corporation that promotes healthcare and wellness benefits and disease prevention through grant-making and community health initiatives. The Foundation has committed approximately $53 million to community initiatives since 2021, awarding grants to nonprofits in cities such as Baltimore, Houston, Chicago, Paterson, and Miami-Dade County, with a focus on maternal health, cardiometabolic outcomes, food security, and health equity in underserved communities.
Is Quest Diagnostics Foundation a public or private company?
Quest Diagnostics Foundation is a public company. It is classified as nonprofit foundation owned and is currently operating.
When was Quest Diagnostics Foundation founded?
Quest Diagnostics Foundation was founded in 1991. It employs 5,001 to 10,000 people.
Where is Quest Diagnostics Foundation based?
Quest Diagnostics Foundation is headquartered in Secaucus, United States, in the North America region.
How does Quest Diagnostics Foundation make money?
Five revenue lines are on record. Diagnostic Information Services are the primary driver. The others are COVID-19 Testing, consumer-Initiated Testing, enterprise/B2B Services and base Business Revenues.
Who are Quest Diagnostics Foundation's main competitors?
Direct peers on record are Pfizer Foundation, Eli Lilly Foundation, Bristol Myers Squibb Foundation, Kaiser Permanente Community Health, UnitedHealth Foundation and ARUP Laboratories. Broad incumbents are Robert Wood Johnson Foundation, CDC Foundation, Sonic Healthcare and Labcorp (Laboratory Corporation of America).
Does Quest Diagnostics Foundation have an API?
No public API is recorded for Quest Diagnostics Foundation.
What industry is Quest Diagnostics Foundation in?
Quest Diagnostics Foundation's product category is Healthcare Philanthropy. Its primary akta.pro industry code is BPAGAKAL, Health & Medical Research Grantmaking Foundations, with a secondary code of BPAGACAC, Community Health, Prevention & Health Education. Its NAICS code is 813211 and its SIC code is 8300.